Daiwa SB Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,556	Closed	-$182K	–	243
2017 Q1	$182K	Sell	3,556 -4,555	-56%	-$233K	0.05%	130
2016 Q4	$304K	Buy	8,111 +3,300	+69%	+$124K	0.08%	114
2016 Q3	$326K	Buy	+4,811	New	+$326K	0.08%	117